The effect of single-nucleotide polymorphisms in the genes encoding methylenetetrahydrofolate reductase, methionine synthase, betaine-homocysteine S-methyltransferase, and cystathionine beta-synthase on homocysteine levels and the risk of ischemic stroke

I. Strokina; N. Motorna

1. Masud R, Khan AUH, Anjum AF, Jawwad G, Azeem Z, Baqai HZ, et al. The Connotation of Variances in the Risk Predictors, Medications, Homocysteine, and Homocysteine Pathway Gene Polymorphisms with CVA/Stroke. Glob Med Genet. 2020;7(4):113-120. doi: 10.1055/s0041-1722884.

2. Munshi A, Kaul S. Genetic basis of stroke: an overview. Neurol India. 2010;58(2):185-190. doi:10.4103/0028-3886.63780

3. Cao M, Zhang Y, Chen D, Zhong J, Zhang X, Yang L, et al. Polymorphism in genes encoding two fatty acid binding proteins increases risk of ischemic stroke in a Chinese Han population. Front Genet. 2023;14:1056186. doi:10.3389/ fgene.2023.1056186.

4. Liu X, Wang Q, Zhu R. Association of GWAS-susceptibility loci with ischemic stroke recurrence in a Han Chinese population. J Gene Med. 2021;23(1):e3264. doi: 10.1002/jgm.3264.

5. Wang Q, Zhao J, Chang H, Liu X, Zhu R. Association between lncRNA ANRIL genetic variants with the susceptibility to ischemic stroke: From a case-control study to meta-analysis. Medicine (Baltimore). 2021;100(11):e25113. doi: 10.1097/MD.0000000000025113.

6. Chen L, Zhang G, Li Q, Lin R. Variant Rs556621 on Chromosome 6p21.1 and the Risk of Ischemic Stroke in Chinese Populations: A Meta-Analysis. Clin Appl Thromb Hemost. 2022;28:10760296221076479. doi: 10.1177/10760296221076479.

7. Appunni S, Rubens M, Ramamoorthy V, Saxena A, McGranaghan P, Veledar E. Stroke Genomics: Current Knowledge, Clinical Applications and Future Possibilities. Brain Sci. 2022;12(3):302. doi: 10.3390/brainsci12030302.

8. Deng XD, Ke JL, Chen TY, Gao Q, Zhao ZL, Zhang W, et al. ERCC1 polymorphism and its expression associated with ischemic stroke in Chinese population. Front Neurol. 2023;13:998428. doi:10.3389/fneur.2022.998428.

9. Domingues-Montanari S, Fernández-Cadenas I, del Rio-Espinola A, Corbeto N, Krug T, Manso H, et al. Association of a genetic variant in the ALOX5AP with higher risk of ischemic stroke: a case-control, meta-analysis and functional study. Cerebrovasc Dis. 2010;29(6):528- 37. doi: 10.1159/000302738.

10. Chen W, Zhu X, Hu Y, Hong H, Kuang L, Liang N, et al. Association of C-reactive protein gene polymorphisms with the risk of ischemic stroke: A systematic review and meta-analysis. Brain Behav. 2023 Jun;13(6):e2976. doi: 10.1002/brb3.2976.

11.Pavlenko OUr, Strokina IG, Drevytska TI, Karvatsky IM, Sokurenko LM, Dosenko VE. Association between risk of ischemic stroke and the rs17216473 single nucleotide polymorphism in the 5-lipoxygenase-activating protein gene locus. Medicni perspektivi. 2025; 30(1):12-21. DOI:https://doi.org/10.26641/2307- 0404.2025.1.325230

12. Wei LK, Au A, Menon S, Griffiths LR, Kooi CW, Irene L, et al. Polymorphisms of MTHFR, eNOS, ACE, AGT, ApoE, PON1, PDE4D, and Ischemic Stroke: Meta-Analysis. J Stroke Cerebrovasc Dis. 2017;26(11):2482-2493. doi: 10.1016/j.jstrokecerebrovasdis.2017.05.048.

13.Zarembska E, Ślusarczyk K, Wrzosek M. The Implication of a Polymorphism in the Methylenetetrahydrofolate Reductase Gene in Homocysteine Metabolism and Related Civilisation Diseases. Int J Mol Sci. 2023;25(1):193. Published 2023 Dec 22. doi:10.3390/ijms25010193

14.Mialovytska O, Nebor Y. ANALYSIS OF RELATIONSHIP BETWEEN POLYMORPHISM OF MTHFR (C677T), MTHFR (A1298C), MTR (A2756G) GENES IN THE DEVELOPMENT OF ISCHEMIC STROKE IN YOUNG PATIENTS. Georgian Med News. 2021;(319):87-92.

15.Yamada K, Chen Z, Rozen R, Matthews RG. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci U S A. 2001;98(26):14853-8. doi: 10.1073/ pnas.261469998.

16. Bickel C, Schnabel RB, Zengin E, Lubos E, Rupprecht H, Lackner K, et al. Homocysteine concentration in coronary artery disease: Influence of three common single nucleotide polymorphisms. Nutr Metab Cardiovasc Dis. 2017;27(2):168-175. doi: 10.1016/j.numecd.2016.09.005.

17. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 1998;338(15):1042- 1050. doi:10.1056/NEJM199804093381507

18. Paradkar MU, Padate B, Shah SAV, Vora H, Ashavaid TF. Association of Genetic Variants with Hyperhomocysteinemia in Indian Patients with Thrombosis. Indian J Clin Biochem. 2020;35(4):465-473. doi: 10.1007/s12291-019- 00846-9.

19. Habib SS, Al-Khlaiwi T, Almushawah A, Alsomali A, Habib SA. Homocysteine as a predictor and prognostic marker of atherosclerotic cardiovascular disease: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2023;27(18):8598-8608. doi:10.26355/eurrev_202309_33784

20. Zaric BL, Obradovic M, Bajic V, Haidara MA, Jovanovic M, Isenovic ER. Homocysteine and Hyperhomocysteinaemia. Curr Med Chem. 2019;26(16):2948-2961. doi:10.2174/09298673 25666180313105949

21.Zhang WH, Zhao SM, Guo JF, Liu YP, Jiang YQ. BHMT polymorphism and susceptibility to PTE in Chinese patients [published correction appears in Eur Rev Med Pharmacol Sci. 2023 Jul;27(13):5947. doi: 10.26355/eurrev_202307_32944.]. Eur Rev Med Pharmacol Sci. 2023;27(9):4098-4102. doi:10.26355/eurrev_202305_32317

22. Hu XJ, Su MR, Cao BW, Ou FB, Yin RX, Luo AD. Relationship between the methylenetetrahydrofolate reductase (MTHFR) rs1801133 SNP and serum homocysteine levels of Zhuang hypertensive patients in the central region of Guangxi. Clin Hypertens. 2023;29(1):26. doi: 10.1186/s40885-023-00250-9.

23. Zhu J, Chen Y, Cao X, Li Q, Shao L, Teng X, et al. Generation of a Human iPSC (ICSSUi002-A) with MTHFR SNP (rs1801133, TT) from Thoracic Aortic Dissection Patient. Stem Cell Res. 2022;61:102753. doi: 10.1016/j. scr.2022.102753.

24.Fu L, Li YN, Luo D, Deng S, Hu YQ. Plausible relationship between homocysteine and obesity risk via MTHFR gene: a meta-analysis of 38,317 individuals implementing Mendelian randomization. Diabetes Metab Syndr Obes. 2019;12:1201-1212. Published 2019 Jul 23. doi:10.2147/DMSO.S205379

25.Weiberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetehydrofolate reductase (MTHFR) association with decreased enzyme activity. Mol Genet Metab. 1998;64:169–172. doi: 10.1006/mgme.1998.2714.

26.Saha T, Chatterjee M, Verma D, Ray A, Sinha S, Rajamma U, et al. Genetic variants of the folate metabolic system and mild hyperhomocysteinemia may affect ADHD associated behavioral problems. Prog Neuropsychopharmacol Biol Psychiatry. 2018;84(Pt A):1-10. doi: 10.1016/j. pnpbp.2018.01.016.

27.Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7–9. doi: 10.1161/01.cir.93.1.7.

28.Masud R, Baqai HZ. The communal relation of MTHFR, MTR, ACE gene polymorphisms and hyperhomocysteinemia as conceivable risk of coronary artery disease. Appl Physiol Nutr Metab. 2017;42(10):1009-1014. doi: 10.1139/ apnm-2017-0030.

29.Yakub M, Moti N, Parveen S, Chaudhry B, Azam I, Iqbal MP. Polymorphisms in MTHFR, MS and CBS genes and homocysteine levels in a Pakistani population. PLoS One. 2012;7(3):e33222. doi: 10.1371/journal.pone.0033222.

30.Liang S, Zhou Y, Wang H, Qian Y, Ma D, Tian W, et al. The effect of multiple single nucleotide polymorphisms in the folic acid pathway genes on homocysteine metabolism. Biomed Res Int. 2014;2014:560183. doi: 10.1155/2014/560183.

31.Clifford AJ, Chen K, McWade L, Rincon G, Kim SH, Holstege DM, et al. Gender and single nucleotide polymorphisms in MTHFR, BHMT, SPTLC1, CRBP2, CETP, and SCARB1 are significant predictors of plasma homocysteine normalized by RBC folate in healthy adults. J Nutr. 2012;142(9):1764-71. doi: 10.3945/ jn.112.160333.

32.Ding R, Lin S, Chen D. The association of cystathionine β synthase (CBS) T833C polymorphism and the risk of stroke: a meta-analysis. J Neurol Sci. 2012;312(1-2):26-30. doi:10.1016/j. jns.2011.08.029

33.Chen C, Gan YY. The allele frequencies of three polymorphisms in genes involved in homocysteine metabolism in a group of unrelated healthy Singaporeans. Dis Markers. 2010;29(2):111-9. doi: 10.3233/DMA-2010-0741.

34.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for re-porting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.

35.Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35–41. doi: 10.1161/01. str.24.1.35.

36. Pashkovskyi VM. Differential diagnosis of ischemic stroke subtypes. Practical Angiology. 2011;(2-1). Available from: https://angiology. com.ua/en/archive/2011/2-1/article-395/diferenciyna-diagnostika-pidtipiv-ishemichnogo-insultu.

37. Imbard A, Toumazi A, Magréault S, Garcia-Segarra N, Schlemmer D, Kaguelidou F, et al. Efficacy and pharmacokinetics of betaine in CBS and cblC deficiencies: a cross-over randomized controlled trial. Orphanet J Rare Dis. 2022;17(1):417. doi: 10.1186/s13023-022- 02567-4.

38.Raghubeer S, Matsha TE. Methylenetetrahydrofolate (MTHFR), the One-Carbon Cycle, and Cardiovascular Risks. Nutrients. 2021;13(12):4562. doi: 10.3390/nu13124562.

39. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111-3. doi: 10.1038/ ng0595-111.

40.Bahadır A, Eroz R, Türker Y. Does the MTHFR C677T gene polymorphism indicate cardiovascular disease risk in type 2 diabetes mellitus patients?. Anatol J Cardiol. 2015;15(7):524-530. doi:10.5152/akd.2014.5555

41.Xu Y, Yan C, Hao Z, Zhou J, Fan S, Tai S, et al. Association between BHMT gene rs3733890 polymorphism and cancer risk: evidence from a meta-analysis. Onco Targets Ther. 2016;9:5225- 33. doi: 10.2147/OTT.S103901.

42. Hsu FC, Sides EG, Mychaleckyj JC, Worrall BB, Elias GA, Liu Y, et al. Transcobalamin 2 variant associated with poststroke homocysteine modifies recurrent stroke risk. Neurology. 2011;77(16):1543-50. doi: 10.1212/ WNL.0b013e318233b1f9.

43.Kruger WD, Evans AA, Wang L, Malinow MR, Duell PB, Anderson PH, et al. Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid. Mol Genet Metab. 2000;70(1):53-60. doi: 10.1006/mgme.2000.2993.

44.Chmurzynska A, Malinowska AM, Twardowska-Rajewska J, Gawecki J. Rs6586282 of the CBS Gene: Its Lack of Eff ect on Homocysteine Concentrations, and Interaction Eff ects on Body Weight in Elderly Women. Int J Vitam Nutr Res. 2016;86(3-4):235-241. doi: 10.1024/0300- 9831/a000284.

45.Summers CM, Hammons AL, Mitchell LE, Woodside JV, Yarnell JW, Young IS, et al. Influence of the cystathionine beta-synthase 844ins68 and methylenetetrahydrofolate reductase 677C>T polymorphisms on folate and homocysteine concentrations. Eur J Hum Genet. 2008;16(8):1010-3. doi: 10.1038/ejhg.2008.69.

46.Tsai MY, Bignell M, Schwichtenberg K, Hanson NQ. High prevalence of a mutation in the cystathionine beta-synthase gene. Am J Hum Genet. 1996;59:1262–1267.

47.De Stefano V, Dekou V, Nicaud V, Chasse JF, London J, Stansbie D, et al. Linkage disequilibrium at the cystathionine beta synthase (CBS) locus and the association between genetic variation at the CBS locus and plasma levels of homocysteine. The Ears II Group. European Atherosclerosis Research Study. Ann Hum Genet. 1998;62(Pt 6):481-90. doi: 10.1046/j.1469- 1809.1998.6260481.x. PMID: 10363126.

48.Dekou V, Gudnason V, Hawe E, Miller GJ, Stansbie D, Humphries SE. Gene-environment and gene-gene interaction in the determination of plasma homocysteine levels in healthy middle-aged men. Thromb Haemost. 2001;85(1):67-74.